Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function

Cell Death and Differentiation

Volumn 12, Issue 11, 2005, Pages 1429-1438

  Del Bufalo, D ^a   Rizzo, A ^a   Trisciuoglio, D ^a   Cardinali, G ^b   Torrisi, M R ^c   Zangemeister Wittke, U ^d   Zupi, G ^a   Biroccio, A ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Apoptosis; bcl 2; Mitochondria; Telomerase

Indexed keywords

2 AMINO 6 BROMO 4 (1 CYANO 2 ETHOXY 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID ETHYL ESTER; ANTISENSE OLIGONUCLEOTIDE; CYTOCHROME C; MUTANT PROTEIN; PROTEIN BCL 2; PROTEIN P53; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

APOPTOSIS; ARTICLE; CATALYSIS; CELL PROTECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RNA INTERFERENCE; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; WESTERN BLOTTING; WILD TYPE;

APOPTOSIS; BENZOPYRANS; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENES, P53; HCT116 CELLS; HUMANS; MITOCHONDRIA; NEOPLASMS; NITRILES; PROTO-ONCOGENE PROTEINS C-BCL-2; TELOMERASE; THIONUCLEOTIDES; TRANSFECTION;

EID: 27344446189     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401670     Document Type: Article

References (52)

1. Morin GB (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529
2. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S and Wright WE (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352
3. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC and Yu J (1995) The RNA component of human telomerase. Science 269: 1236-1241
4. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959
5. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I and Robinson MO (1997) A mammalian telomerase-associated protein. Science 275: 973-977
6. Vaziri H and Benchimol S (1998) Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8: 279-282
7. Fu W, Begley JG, Killen MW and Mattson MP (1999) Anti-apoptotic role of telomerase in pheochromocytoma cells. J. Biol. Chem. 274: 7264-7271
8. Karlseder J, Broccoli D, Dai Y, Hardy S and de Lange T (1999) p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283: 1321-1325
9. Zhang X, Mar V, Zhou W, Harrington L and Robinson MO (1999) Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 13: 2388-2399
10. Fu W, Killen M, Culmsee C, Dhar S, Pandita TK and Mattson MP (2000) The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J. Mol. Neurosci. 14: 3-15
11. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JH, Meyerson M and Weinberg RA (1999) Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5: 1164-1170
12. Saretzki G, Ludwig A, von Zglinicki T and Runnebaum IB (2001) Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells. Cancer Gene Ther. 8: 827-834
13. Kraemer K, Fuessel S, Schmidt U, Kotzsch M, Schwenzer B, Wirth MP and Meye A (2003) Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin. Cancer Res. 9: 3794-3800
14. Blackburn EH (2000) Telomere states and cell fates. Nature 408: 53-56
15. Kondo Y, Kondo S, Tanaka Y, Haqqi T, Barna BP and Cowell JK (1998) Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene 16: 2243-2248
16. Ludwig A, Saretzki G, Holm PS, Tiemann F, Lorenz M, Emrich T, Harley CB and von Zglinicki T (2001) Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase. Cancer Res. 61: 3053-3061
17. Harley CB and Sherwood SW (1997) Telomerase, checkpoints and cancer. Cancer Surv. 29: 263-284
18. Lu C, Fu W and Mattson MP (2001) Telomerase protects developing neurons against DNA damage-induced cell death. Brain Res. Dev. Brain Res. 131: 167-171
19. Ren JG, Xia HL, Tian YM, Just T, Cai GP and Dai YR (2001) Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett. 488: 133-138
20. Boise LH, Gottschalk AR, Quintans J and Thompson CB (1995) Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Curr. Top Microbiol. Immunol. 200: 107-121
21. Korsmeyer SJ (1995) Regulators of cell death. Trends Genet. 11: 101-105
22. Carson DA and Ribeiro JM (1993) Apoptosis and disease. Lancet 341: 1251-1254
23. Mandal M and Kumar R (1996) Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. Cell Growth Differ. 7: 311-3118
24. Mandal M, Maggirwar SB, Sharma N, Kaufmann SH, Sun SC and Kumar R (11996) Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NFkappaB signaling pathway. J. Biol. Chem. 271: 30354-30359
25. Mandal M and Kumar R (1997) Bcl-2 modulates telomerase activity. J. Biol. Chem. 272: 14183-14187
26. Catalano A, Romano M, Robuffo I, Strizzi L and Procopio A (2001) Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity. Am. J. Pathol. 159: 721-731
27. Wang JL, Liu D, Zhang ZJ, Shan S, Han X, Srinivasula SM, Croce CM, Alnemri ES and Huang Z (2000) Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc. Natl. Acad. Sci. USA 97: 7124-7129
28. Zangemeister-Wittke U, Leech SH, Olie RA, Simoes-Wust AP, Gautschi O, Luedke GH, Natt F, Haner R, Martin P, Hall J, Nalin CM and Stahel RA (2000) A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells. Clin. Cancer Res. 6: 2547-2555
29. Gautschi O, Tschopp S, Olie RA, Leech SH, Shoes-Wust AP, Ziegler A, Baumann B, Odermatt B, Hall J, Stahel RA and Zangemeister-Wittke U (2001) Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins. J. Nat Cancer Inst. 93: 463-471
30. Pei XY, Dai Y and Grant S (2003) The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells. Leukemia 17: 2036-2045
31. Liu K, Hodes RJ and Wang Np (2001) Cutting edge: Telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J. Immunol. 166: 4826-4830
32. Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, Yamane K and Tsuruo T (2000) Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J. 19: 2652-2661
33. Del Bufalo, D, Biroccio A, Leonetti C and Zupi G (1997) Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. FASEB J. 11: 947-953
34. Xu D, Wang Q, Gruber A, Bjorkholm M, Chen Z, Zaid A, Selivanova G, Peterson C, Wiman KG and Pisa P (2000) Downregulation of telomerase reverse transcriptase mRNA expression by wild-type p53 in human tumor cells. Oncogene 19: 5123-5133
35. Trisciuoglio D, Iervolino A, Candiloro A, Fibbi G, Fanciulli M, Zangemeister-Wittke U, Zupi G and Del Bufalo D (2004) bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: Involvement of ERK1/ERK2 activity. J. Biol. Chem. 279: 6737-6745
36. Ricca A, Biroccio A, Del Bufalo D, Mackay AR, Santoni A and Cippitelli M (2000) bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells. Int. J. Cancer 86: 188-196
37. Minamino T and Kourembanas S (2001) Mechanisms of telomerase induction during vascular smooth muscle cell proliferation. Circ. Res. 89: 237-243
38. Haendeler J, Hoffmann J, Brandes RP, Zeiher AM and Dimmeler S (2003) Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol. Cell. Biol. 23: 4598-4610
39. Haendeler J, Hoffmann J, Diehl JF, Vasa M, Spyridopoulos I, Zeiher AM and Dimmeler S (2004) Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ. Res. 94: 768-775
40. Hamann MT, Rudolph KL, Strong MA, DePinho RA, Chin L and Greider CW (2001) Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol. Biol. Cell. 12: 2023-2030
41. Mattson MP and Klapper W (2001) Emerging roles for telomerase in neuronal development and apoptosis. J. Neurosi. Res. 63: 1-9
42. Oh H, Taffet GE, Youker KA, Entman ML, Overbeek PA, Michael LH and Schneider MD (2001) Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc. Natl. Acad. Sci. USA. 98: 10308-10313
43. Wong KK, Chang S, Weiler SR, Ganesan S, Chaudhuri J, Zhu C, Artandi SE, Rudolph KL, Gottlieb GJ, Chin L, Alt FW and DePinho RA (2000) Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat. Genet. 26: 85-88
44. Zhu H, Fu W and Mattson MP (2000) The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J. Neurochem. 75: 117-124
45. Sharma GG, Gupta A, Wang H, Scherthan H, Dhar S, Gandhi V, Iliakis G, Shay JW, Young CS and Pandita TK (2003) hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 22: 131-146
46. Smith LL, Coller HA and Roberts JM (2003) Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell. Biol. 5: 474-479
47. Biroccio A, Amodei S, Benassi B, Scarsella M, Cianciulli A, Mottolese M, Del Bufalo D, Leonetti C and Zupi G (2002) Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones. Oncogene 21: 3011-3019
48. Counter CM, Hahn WC, Wei W, Caddle SD, Beijerbergen RL, Lansdorp PM, Sedivy JM and Weinberg RA (1998) Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. USA 95: 14723-14728
49. Kosciolek BA, Kalantidis K, Tabler M and Rowley PT (2003) Inhibition of telomerase activity in human cancer cells by RNA interference. Mol. Cancer Ther. 2: 209-216
50. Biroccio A, Benassi B, Amodei S, Gabellini C, Del Bufalo D and Zupi G (2001) c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells. Mol. Pharmacol. 60: 174-182
51. Biroccio A, Benassi B, Filomeni G, Amodei S, Marchini S, Chiorino G, Rotilio G, Zupi G and Ciriolo MR (2002) Glutathione influences c-Myc-induced apoptosis in M14 human melanoma cells. J. Biol. Chem. 27: 43763-43770
52. Biroccio A, Benassi B, Fiorentino F and Zupi G (2004) Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents. Neoplasia 6: 195-206